Bayer shares are down 29% since it closed the Monsanto deal in June 2018. At one point last year as juries ruled against the company, Bayer’s market value had fallen below what it paid for Monsanto. As of April, the company had been sued by 52,500 U.S. plaintiffs who blame glyphos...